{"name":"Oncolytics Biotech","slug":"oncolytics-biotech","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE02YUVZamJ3Zzg4WHJueWdRWFRFY0VaalI5S25JOHMyR3p5al9UTUNvdzd0TGI0N0JjelhsRDZXc3BEdVhSVXZYWXZnQUZmeHZRSkR1RWFNS0RjWFR3NXVBY1BnZ1RwMWFjR0JJUW9obWlXM0hBWXk40gF8QVVfeXFMTkhQeXBLd1M1cUpwc2RDc0pYa3FNTU9TR2pfUkhkeTh5VWlaaXNpcUVMZlB6S3oweUFvVERwOGRNWUZvdnh6TUdMYkNncDdwXzRwdlkxUWx2UzJTQ2RFajhvYmprbFRnS0xjZXpOWU51UUxCc3N1QzF6d1Qzcw?oc=5","date":"2026-02-13","type":"pipeline","source":"Pulse 2.0","summary":"Oncolytics Biotech: Interview With CEO & Director Jared Kelly About The Immunotherapy Company - Pulse 2.0","headline":"Oncolytics Biotech: Interview With CEO & Director Jared Kelly About The Immunotherapy Company - Pulse 2.0","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxOWnU3YnJCYzNuV0Y1RUFWQXpUYlFDTXhGa1hlMnhGRjAyRy01WXNJc05KSmd3RUVKZmV0aUxXWjVPbkV2dkhwb0s1NFdOWTRKSUVvYW8zdFNGSGJQSG5NMzFVQnB3WC12dS1ZQ3VPQnJ0a3pkVzdfTUlaMmV1bEp4VVJ1YS1QTmRBYlpJOGNYQ0c0M3VFcmZyeVhLTnJQcENYcmdkTHNWSmZiam45YlBwRVI0eHhJNkJPX0ZjdE1mZ2hOX0c5dVRNeUZtOU1LUzNpQjJhZ2NwNmpTQlBoSlh0VmpxbDBaWkZQX05YVmlvMFRzZXc2bnBRd2RrS3hNZFphTVhkT2hCc3BMUlliNHd3bXl3ZnJXa3M5NEFqR1ZNdHlERG_SAaMCQVVfeXFMTlp1N2JyQmMzbldGNUVBVkF6VGJRQ014RmtYZTJ4RkYwMkctNVlzSXNOSkpnd0VFSmZldGlMV1o1T25FdnZIcG9LNTRXTlk0SklFb2FvM3RTRkhiUEhuTTMxVUJwd1gtdnUtWUN1T0JydGt6ZFc3X01JWjJldWxKeFVSdWEtUE5kQWJaSThjWENHNDN1RXJmcnlYS05yUHBDWHJnZExzVkpmYmpuOWJQcEVSNHh4STZCT19GY3RNZmdoTl9HOXVUTXlGbTlNS1MzaUIyYWdjcDZqU0JQaEpYdFZqcWwwWlpGUF9OWFZpbzBUc2V3Nm5wUXdka0t4TWRaYU1YZE9oQnNwTFJZYjR3d215d2ZyV2tzOTRBakdWTXR5RERv?oc=5","date":"2026-02-04","type":"trial","source":"Bolsamania","summary":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Bolsamania","headline":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNR1JEdmhuTFJUM01uanVCZy1WdEtmeDF6ZUVGMnhoMGM3enljcVVtaDZKU0NMTlFUQ3d4M1ljcDBwbFVXZEFhV1p4b1VsMElFaktFRFYwaUxSRGNmeGduY21lZ1FWRWdyTGFMU2lXVUJxTlpCZ01VSDk1cWFfSkNmRnd2OVk4ejBkUFJwNEpSNThqZU5McEk5N1hqY19SXzctdHYtU05Gd3RLdHBab05JdjFTVjNkdWhqUTFobFFfZzhGXzZSS004QUdsTjFrWkQxRnc?oc=5","date":"2026-01-30","type":"deal","source":"prnewswire.com","summary":"$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium - prnewswire.com","headline":"$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNNGVpUFhJZW9tODl4ZFRiMGM5NDljUW9LRHppUVM2bXBVbFhUMEVWX1RCanQ3dWt5WV9URl9zLVVaVVpJa0lIbUNNYTNnRGduRE5iTGoyeUlNSm9zQ2ROSkZDZmQ4QUF3R0cyWTIzcTFBX1BTRXRYLU5kSVBFdnJMNi1CX1dLWm5tdEdoLU5UUVplOFdhUEVuZ1pvX3JnZFRWYVgwY0RmV1JSdWhMZVhSdTBJX3VTZ25EYzhBUkl3NkpyRTdxNXZybXhoZ1NreTZ6RWgxb3FtSVVKSXJLVTRvVEZkME1zS2VKdUFGWVdlZENfUnd3d3owdjBnMkdfdC1y?oc=5","date":"2026-01-27","type":"pipeline","source":"The Globe and Mail","summary":"Hard-to-Treat Cancers: How 2026’s Top Clinical Platforms Are Beating Industry Benchmarks - The Globe and Mail","headline":"Hard-to-Treat Cancers: How 2026’s Top Clinical Platforms Are Beating Industry Benchmarks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOQWsxaTRKZHdTalhSWlJUYUsyLVpibzZNNzE2SjludWlxay1xQVRIT2lGOVpXUGxDOWZhdVl2UGZJbGhuZUxodk5WWlFzV2h5SXc4SXFWTkxXeDdWUmUxczMwU2I5QnlrOXpwT1BLY0NwNnhyZ3o5M0luVzZLTy12bkU0S0VMS2tocHBTc0I2SjVjbEhvUnYwZnVRRTktMXRKSjgyVXlSbE5qTlRwRmtmWGdPMmdpeUZ2TmNCeERPaXl1SXNieFRGZkNvTHA2Wl9yUmc?oc=5","date":"2026-01-14","type":"patent","source":"prnewswire.com","summary":"Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff - prnewswire.com","headline":"Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPTDNxQ0JQd2pSLTBOaW5VUVlNOHV4blhGakdoNlgwWDVrMDE3VVh0Q0pDZF9HUkxsZmhEQ2dqSmlyNFVNNXJkRzgyUFBSV1E4S04yVnpaODdzYWpBTXFZblVObFNQVWttWjJld0E2bGd2NFQ0WUN5NXRBVnBZemZaWVdLVkczT2pNX2ljVFNuMllReVdFNjlaZUo3ak1NYVVIUFNrZEMtcWtsMmxZcS1nb1F1bmExU3JNWDlITXZIVzl0MkRZT3cySWlYQXVIb2lmZFI1Z0VKM2pmemwydEtSMg?oc=5","date":"2026-01-08","type":"pipeline","source":"GlobeNewswire","summary":"The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech - GlobeNewswire","headline":"The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNRFlFSkJ2aE5JVUpPSkRoV1V3c0tyNWZ5dkdlLVRtdWVLLWhNRzBFNklKRjg0R3BSbjFTeFduWWRfMXNRWmlYdWEzQjdOM3A0ZVBPbGZ0ZUFDaTM3X3JzMGpyTV9JcXZKc19qQjlsWGxQRVhHajlRNDY1QjVvek11QnZNT1lPaUVOVnFROTA4VFFfYzZ4V0ZibTRwTm5FTHR1R0xLOTA4cmJnc2tKMTBSQ3lvWjI1c2Q1Z1E?oc=5","date":"2026-01-08","type":"pipeline","source":"AD HOC NEWS","summary":"The Truth About Oncolytics Biotech (ONCY): Hidden Gem Or Total Trap? - AD HOC NEWS","headline":"The Truth About Oncolytics Biotech (ONCY): Hidden Gem Or Total Trap?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-03","type":"pipeline","source":"simplywall.st","summary":"Is Oncolytics Biotech (NASDAQ:ONCY) In A Good Position To Deliver On Growth Plans? - simplywall.st","headline":"Is Oncolytics Biotech (NASDAQ:ONCY) In A Good Position To Deliver On Growth Plans?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOVmJHNlR0UzdvSW1Oa3RRaUtfSTF5bUtzYXRvdER3RmRxbER0VTdsTjEyaUhzalJub05PVGdzSVJOamUwTi0yRTE5Rk5lVGJfNWt3RUFCM19kbXBwNFZyZzJ4OXZPdTc4VVZ1X0gzNElSMXBmd052TUZfdlMxelo5UHVxY25YaGhHdjVtb21jMFdXOWozMC1pcWVGcEdENHkwX1BPVEV5aEg?oc=5","date":"2025-07-11","type":"pipeline","source":"Fierce Biotech","summary":"Pfizer’s reputation wrangler plans departure—Chutes & Ladders - Fierce Biotech","headline":"Pfizer’s reputation wrangler plans departure—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE0yUXlfVk1WNWpTN3Z5T3dCSE9iakF3TWJkV2xzR2xqSy1KSklzZG4tMzNSdFAtR2ZPZ3NvR0VsS1BCLS1iWnRINzJLVXF2S2xNTk5DZkdTOUZwLVJ1WjlZ?oc=5","date":"2025-06-17","type":"pipeline","source":"The Pharma Letter","summary":"Oncolytics Biotech - The Pharma Letter","headline":"Oncolytics Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxQV0dxSHFLTmZZYU5zNlJtYTgzdDFYaExZUGd5WmFFTmRZZ3N4TFRfRlNkcl95aUJsM0xZNTZSb19JeW1XMUtId19rRnd0Q0NXRzRIR2RmZWZqM2M3eV8wbkJzV2VQV2Z3QWotM0RZcEUxVGwtbDRvbmZQU3UxVnZzU0lKZkJWY3RsVklHYjE3bGdObDJqSFZtTnN0S2FKazBnQk9Wb21wc0JYaHlpOWFXVE5kMmZqWWNtT1pDM1ZXV2VHalYxZE90WncxSllxVTRFS0lONWdGUEdJWXNVSW01V245Njk5TUtmVW81dXlGOA?oc=5","date":"2025-06-05","type":"trial","source":"CRISPR Medicine News","summary":"Press Release Service: Oncolytic Virus Immunotherapy Strategic Research Business Report 2025-2030: Surge in Clinical Trials Combining Oncolytic Viruses With Checkpoint Inhibitors Expands Therapeutic H","headline":"Press Release Service: Oncolytic Virus Immunotherapy Strategic Research Business Report 2025-2030: Surge in Clinical Tri","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE5FYUFJUWlmR2RSdVloZUZ1M3laekxSTXRxX2NNTDBnWEU2UWpSWGhJR2xrMnZ1aUtnMGI0YjJUczQyZnIyX3BTZ1ROMXRaMGxGd2FxcDNOTlhUcTBkTlBSZk5iVTBLYURDVk11OEstbFVpaUY4?oc=5","date":"2025-03-19","type":"pipeline","source":"Pharmaceutical Executive","summary":"New Ways of Targeting Cancer: Q&A with Oncolytics Biotech - Pharmaceutical Executive","headline":"New Ways of Targeting Cancer: Q&A with Oncolytics Biotech","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}